Jane Street’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $322M | Buy |
2,521,200
+592,200
| +31% | +$73.9M | 0.04% | 279 |
|
|
2025
Q4 | $235M | Sell |
1,929,000
-642,900
| -25% | -$73.7M | 0.04% | 307 |
|
|
2025
Q3 | $258M | Buy |
2,571,900
+1,050,000
| +69% | +$94.6M | 0.04% | 288 |
|
|
2025
Q2 | $126M | Buy |
1,521,900
+314,500
| +26% | +$25.1M | 0.03% | 393 |
|
|
2025
Q1 | $97.9M | Sell |
1,207,400
-170,100
| -12% | -$15.2M | 0.02% | 385 |
|
|
2024
Q4 | $124M | Sell |
1,377,500
-719,600
| -34% | -$69.7M | 0.03% | 362 |
|
|
2024
Q3 | $207M | Buy |
+2,097,100
| New | +$206M | 0.05% | 218 |
|
|
2022
Q2 | – | Sell |
-1,058,000
| Closed | -$95.1M | – | 11057 |
|
|
2022
Q1 | $95.1M | Buy |
1,058,000
+138,100
| +15% | +$12.8M | 0.03% | 422 |
|
|
2021
Q4 | $103M | Buy |
919,900
+503,600
| +121% | +$60.7M | 0.03% | 359 |
|
|
2021
Q3 | $52.3M | Sell |
416,300
-168,700
| -29% | -$21.7M | 0.02% | 584 |
|
|
2021
Q2 | $79.2M | Sell |
585,000
-700,600
| -54% | -$92.1M | 0.03% | 376 |
|
|
2021
Q1 | $174M | Buy |
1,285,600
+183,300
| +17% | +$27.4M | 0.09% | 159 |
|
|
2020
Q4 | $155M | Buy |
1,102,300
+417,200
| +61% | +$53.4M | 0.08% | 157 |
|
|
2020
Q3 | $76.3M | Sell |
685,100
-141,700
| -17% | -$15.9M | 0.05% | 281 |
|
|
2020
Q2 | $92.6M | Buy |
826,800
+542,400
| +191% | +$53.4M | 0.07% | 201 |
|
|
2020
Q1 | $22M | Sell |
284,400
-671,800
| -70% | -$59.5M | 0.02% | 422 |
|
|
2019
Q4 | $90.9M | Buy |
956,200
+341,700
| +56% | +$29.6M | 0.13% | 101 |
|
|
2019
Q3 | $46.9M | Buy |
614,500
+298,200
| +94% | +$24.8M | 0.08% | 181 |
|
|
2019
Q2 | $27.7M | Sell |
316,300
-192,700
| -38% | -$16.4M | 0.05% | 294 |
|
|
2019
Q1 | $46.1M | Sell |
509,000
-1,844,200
| -78% | -$157M | 0.08% | 190 |
|
|
2018
Q4 | $169M | Buy |
2,353,200
+1,772,300
| +305% | +$143M | 0.36% | 42 |
|
|
2018
Q3 | $55.7M | Sell |
580,900
-210,600
| -27% | -$20.4M | 0.11% | 114 |
|
|
2018
Q2 | $75.3M | Buy |
791,500
+455,400
| +135% | +$41.9M | 0.18% | 71 |
|
|
2018
Q1 | $29.5M | Buy |
336,100
+42,100
| +14% | +$3.84M | 0.08% | 200 |
|
|
2017
Q4 | $25M | Sell |
294,000
-44,500
| -13% | -$3.73M | 0.07% | 243 |
|
|
2017
Q3 | $29.3M | Buy |
338,500
+103,400
| +44% | +$8.29M | 0.09% | 191 |
|
|
2017
Q2 | $18.1M | Sell |
235,100
-207,100
| -47% | -$14.7M | 0.06% | 264 |
|
|
2017
Q1 | $30.7M | Sell |
442,200
-215,700
| -33% | -$14.5M | 0.14% | 130 |
|
|
2016
Q4 | $38.9M | Sell |
657,900
-769,100
| -54% | -$47.5M | 0.17% | 101 |
|
|
2016
Q3 | $94.6M | Buy |
1,427,000
+56,200
| +4% | +$3.48M | 0.45% | 42 |
|
|
2016
Q2 | $74.1M | Buy |
1,370,800
+479,900
| +54% | +$26.3M | 0.37% | 47 |
|
|
2016
Q1 | $46M | Buy |
890,900
+327,600
| +58% | +$17M | 0.26% | 71 |
|
|
2015
Q4 | $39.5M | Sell |
563,300
-936,800
| -62% | -$63.9M | 0.25% | 73 |
|
|
2015
Q3 | $93.4M | Buy |
1,500,100
+377,800
| +34% | +$29.8M | 0.59% | 25 |
|
|
2015
Q2 | $94.4M | Buy |
1,122,300
+884,700
| +372% | +$68.8M | 0.61% | 21 |
|
|
2015
Q1 | $17.9M | Buy |
237,600
+24,600
| +12% | +$1.72M | 0.14% | 124 |
|
|
2014
Q4 | $13.2M | Buy |
+213,000
| New | +$12.1M | 0.1% | 154 |
|
|
2014
Q2 | – | Sell |
-266,100
| Closed | -$12.6M | – | 3209 |
|
|
2014
Q1 | $12.6M | Buy |
+266,100
| New | +$13.6M | 0.14% | 103 |
|
Other funds holding XBI
Jane Street's XBI Position: Q1 2026 in Review
Jane Street increased its State Street SPDR S&P Biotech ETF (XBI) stake by 1,190% in Q1 2026, buying an estimated $9.74M and bringing the position to 84,553 shares worth $10.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2443.
Jane Street first reported a position in XBI in Q3 2013 and has held it in 42 quarters since. The position peaked at $281M in Q4 2021. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Jane Street held 84,553 shares of State Street SPDR S&P Biotech ETF worth $10.8M as of Q1 2026.
- Jane Street bought 77,998 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $9.74M.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #2443 holding.
- Jane Street first reported a position in State Street SPDR S&P Biotech ETF in Q3 2013 and has held it in 42 quarters since.
- Jane Street's State Street SPDR S&P Biotech ETF position peaked at $281M in Q4 2021.
- 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.